Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Durbin

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
The Science of the Total Environment|February 21, 2006
A pilot study of children's exposure to CCA-treated wood from playground equipmentS L Shalat, H M Solo-Gabriele, L E Fleming, et al.
Physical Review Letters|July 27, 2019
Alloy-Free Band Gap Tuning across the Visible SpectrumRobert A Makin, Krystal York, Steven M Durbin, et al.
The Astrophysical Journal|October 22, 2019
Young Accreting Compact Objects in M31: The Combined Power of <i>NuSTAR, Chandra</i>, and <i>Hubble</i>M Lazzarini, A E Hornschemeier, B F Williams, et al.
Cancer|October 10, 2024
Financial toxicity in early-phase cancer clinical trial participantsSienna M Durbin, Debra Lundquist, Andrea Pelletier, et al.
JAMA Network Open|March 27, 2025
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor TherapySienna M Durbin, Leyre Zubiri, Katherine Perlman, et al.
The Oncologist|October 12, 2020
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient SettingSienna M Durbin, Leyre Zubiri, Andrzej Niemierko, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2026
Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participantsAnh B Lam, Andrea Pelletier, Sienna M Durbin, et al.
Journal for Immunotherapy of Cancer|June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitisYousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
JCO Oncology Practice|June 10, 2024
Time Toxicity Experienced by Early-Phase Cancer Clinical Trial ParticipantsSienna M Durbin, Debra M Lundquist, Andrea Pelletier, et al.
Genome Biology|July 2, 2014
Human genomic regions with exceptionally high levels of population differentiation identified from 911 whole-genome sequencesVincenza Colonna, Qasim Ayub, Yuan Chen, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
The Science of the Total Environment|February 21, 2006
A pilot study of children's exposure to CCA-treated wood from playground equipmentS L Shalat, H M Solo-Gabriele, L E Fleming, et al.
Physical Review Letters|July 27, 2019
Alloy-Free Band Gap Tuning across the Visible SpectrumRobert A Makin, Krystal York, Steven M Durbin, et al.
The Astrophysical Journal|October 22, 2019
Young Accreting Compact Objects in M31: The Combined Power of <i>NuSTAR, Chandra</i>, and <i>Hubble</i>M Lazzarini, A E Hornschemeier, B F Williams, et al.
Cancer|October 10, 2024
Financial toxicity in early-phase cancer clinical trial participantsSienna M Durbin, Debra Lundquist, Andrea Pelletier, et al.
JAMA Network Open|March 27, 2025
Late-Onset Immune-Related Adverse Events After Immune Checkpoint Inhibitor TherapySienna M Durbin, Leyre Zubiri, Katherine Perlman, et al.
The Oncologist|October 12, 2020
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient SettingSienna M Durbin, Leyre Zubiri, Andrzej Niemierko, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2026
Associations of symptom burden with patient-reported outcomes and clinical outcomes among early phase cancer clinical trial participantsAnh B Lam, Andrea Pelletier, Sienna M Durbin, et al.
Journal for Immunotherapy of Cancer|June 22, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitisYousef R Badran, Fangwen Zou, Sienna M Durbin, et al.
JCO Oncology Practice|June 10, 2024
Time Toxicity Experienced by Early-Phase Cancer Clinical Trial ParticipantsSienna M Durbin, Debra M Lundquist, Andrea Pelletier, et al.
Genome Biology|July 2, 2014
Human genomic regions with exceptionally high levels of population differentiation identified from 911 whole-genome sequencesVincenza Colonna, Qasim Ayub, Yuan Chen, et al.
Pageof 14